Remove Development Remove Doctor Remove Pharma Companies Remove Regulation
article thumbnail

Another reason change is needed at FDA? Fair balance

World of DTC Marketing

As we have seen over the past few years, Pharma companies are a business, a regulated business, but still a business. To portray patients, mindless people who blindly believe DTC TV ads and rush to their doctor to ask for a product are inaccurate. I just finished watching a Zoom call where people evaluated a new DTC spot.

Doctors 165
article thumbnail

Drug development and working with specialised Rare Disease networks

pharmaphorum

During the course of the webinar, Keefer explained how specialty sites, with deep knowledge on one or certain groups of Rare Diseases, are crucial for further progress in drug development to progress the number of treatments available to Rare Disease patients and to provide support to those individuals. Headway being made.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

COVID-19 and the digital pharma marketing revolution

pharmaphorum

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications. This is an increase in 14.2%

article thumbnail

Team behind RECOVERY trial of COVID drugs casts its net wider

pharmaphorum

“The cost of developing a new drug is extortionately high,” said Landray, adding that a very large proportion of those costs is in phase 3, and that means many promising therapies may never be taken forward by pharma companies.

Trials 95
article thumbnail

High hopes as Inventiva takes NASH contender into phase 3

pharmaphorum

The regulator said it wanted more long-term safety and efficacy data from the REGENERATE study before making a final decision on the drug, which had been expected to be the first entrant into a likely multi-billion dollar market niche. billion annually if approved.

article thumbnail

Growth Of Pharma Franchise in India

Creogenic Pharma

Franchise Company. Growth of Pharma Franchise: With the rise in competition, it has truly become demanding for new businesses to enter the present pharmaceutical production marketplace. The operational and marketing skills could be developed with time, but the lack of tools can damage your business very poorly. Distributor ?

article thumbnail

Pfizer deal paves way for approval of ImaginAb’s cancer imaging tech

pharmaphorum

The California-based company has signed a non-exclusive license with Pfizer to supply its 89Zr CD8 Immuno-PET agent, which can be used to image CD8 T cells in cancer patients. Equally important to the company is the safety data gathered as the technology is used as the pharma companies use it to guide development of cancer immunotherapies.

Doctors 53